General News

Garfinkel joins ORC as assistant vice president for research compliance

Mon, 5th February, 2018

Susan Garfinkel

Susan Garfinkel

The Office of Research welcomes Dr. Susan Garfinkel. She joined the Office of Research Compliance as assistant vice president for research compliance in December 2017. Dr. Garfinkel will be responsible for developing, implementing and leading programs and policies to ensure the university is compliant with federal, state and private sponsor requirements as well as university policies to support and promote ethical research practices.

She will serve as the senior coordinator concerning research misconduct, providing oversight and advice to the university’s research integrity officers. Dr. Garfinkel will provide updates to university officials on the progress of any inquiry or investigation and make recommendations for university actions. Working in conjunction with the associate vice president for research compliance, she will coordinate institution-wide research compliance policies and procedures and work with faculty and administrative units to ensure that the university is compliant with federal and state regulations regarding export controls, conflict of interest, research misconduct, international research and research data security. She will also work with faculty, staff, students and administrative units to build awareness and develop strategies for effective ways to minimize and manage compliance risks.

Dr. Garfinkel brings a wealth of experience to this position. From 2013 to present, she served as the director of the Division of Investigative Oversight (DIO) at the U.S. Department of Health and Human Services Office of Research Integrity in Rockville, Maryland. In that position she supervised DIO scientist-investigators and support staff on matters related to case management and investigative strategy for all basic science and clinical research misconduct cases, from preliminary assessment of allegations through case resolution, in all fields of biomedical research. Prior to that, she served as a scientist-investigator for the DIO and director of research grants for the American Health Assistance Foundation.

Dr. Garfinkel received her BA in biology from SUNY at Binghamton and her PhD in genetics from George Washington University.

She is located in the Research Administration building at 1960 Kenny Road, room 204. She can be contacted at or 614-292-7150.

Category : General

2017 COI Disclosure is available on April 17, 2017

Tue, 4th April, 2017

2017 COI Disclosure is available on April 17, 2017


The Ohio State University requires certain faculty, staff members, and students to complete an annual financial disclosure to comply with federal conflict of interest (COI) regulations, accreditation requirements, and OSU faculty and staff COI policies. This year, the new disclosure period begins April 17, 2017 with a required one-year look back period for 2017 going back to April 2016. COI disclosures should be completed by May 17, 2017 by going to

All individuals required to complete a COI disclosure will receive an email, advising them that the new disclosure period has opened, and that their 2017 disclosure should be completed. Instructions on how to complete the disclosure, along with information regarding what needs to be disclosed and how the disclosure is reviewed and approved, will be provided in the email and upon logging into the e-COI system at

If a 2016 disclosure form is on file, it will no longer be editable after April 17, 2017. Please note that the 2016 form will not expire until June 30, 2017. This provides individuals adequate time to complete the 2017 disclosure prior to expiration of the current disclosures. Reminder emails will be sent in May and June to all individuals who are required to, but have not yet completed, the 2017 COI disclosure.

If you have any questions about the research-related COI policy, please see:, or the FAQs at:

The Office of Research Compliance can be reached at 614-292-4284, or

Category : General

Revised Controlled Substances Policy and Forms Effective June 1, 2016

Tue, 31st May, 2016

Revised Controlled Substances Policy and Forms Effective June 1, 2016

The Individual Investigator Use of Controlled Substances in Non-Therapeutic Research policy describes the responsibilities of the university, registrants, and authorized agents who use controlled substances in animal, cell culture, or in-vitro analytical laboratory research and, specifically, their responsibilities to comply with DEA and State of Ohio Board of Pharmacy requirements concerning the administration, handling, storage, destruction, and/or transfer of controlled substances used in such research.

The revision of the policy:

  • incorporates regulations changes,
  • requires background checks to be performed for anyone with access to the controlled substances,
  • centralizes registration and administration at the college level,
  • sets training and inspection standards,
  • standardizes recordkeeping requirements,
  • formalizes current university practices and provides clarity for a university-wide audience.

An overview of the University’s controlled substances program as well as the updated, required forms to be used for documenting the receipt, use, waste, loss/theft, transfer, or disposal of controlled substances in research as well as authorized agent lists are available on the “Controlled Substances” page of our Office of Research Compliance website:

For answers to frequently asked questions, visit

View the entire revised Individual Investigator Use of Controlled Substances in Non-Therapeutic Research policy here:

Category : General